Form 4 Tracker
Evert B. Schimmelpennink

Director, President, CEO and Secretary · 1 filing · Latest: Mar 27, 2026

LENZ Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LENZ
Evert B. SchimmelpenninkDirector, President, CEO and SecretaryMar 27, 2026
Purchase
$8.9528,089$251.4K77,289